Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide be-yond 2.5 years: A case series
DIGESTIVE AND LIVER DISEASE(2021)
摘要
Introduction: While the efficacy and safety of Bulevirtide (BLV) treatment for 48 weeks in compensated HDV cirrhotic patients has been already demonstrated, the long-term effects of this treatment have not been investigated yet.
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要